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Bruton tyrosine kinase (BTK) belong to the Tec family of non receptor tyrosine kinases that is a 
predominant cytoplasmic protein found in cells of humans that is responsible for B-lymphocyte 
development, differentiation, activation and signaling. Having 659 amino acids, the BTK protein 
contains five active domains: Pleckstrin homology (PH), Tec homology (TH), Src homology 3 
(SH3), Src homology 2 (SH2) and Tyrosine kinase domain (TK). Pathogenic genetic variations,  
such as single nucleotide polymorphisms (SNP), in human BTK gene leads to a deficient immune 
condition known as X-linked agammaglobulinemia (XLA). 
Pathogenic variations leading to XLA are traceable to the defected functional sites of the BTK 
protein. Thus, grounding our knowledge of the structural interactions occurring at the protein-
protein interface regions of the BTK protein would assist in understanding the disease 
mechanism as well as  determining the targets for therapeutic agents.  
Six protein-protein interface predictors (cons-PPISP, PredUS, SPPIDER, Meta-PPISP, PPI-Pred 
and PIER) were selected to analyze the interfacial regions of PH, SH2 and kinase domains of 
human BTK protein. In addition, dataset on known pathogenic SNPs in BTK that causes XLA 
were collected from BTKbase and mapped to regions of the predicted protein interface based 
on the prevalence of the variations. The results showed that residues V64 (PH); W281, K284, 
R288 (SH2); G409, T410, Q412, G414, V415, Y617 (TK) are integral constituents of interface 
regions in their respective domains. Statistical analysis of amino acid abundance across 
interface region highlighted arginine as the most abundant across the interface regions of PH, 
SH2 and kinase domain. In addition, arginine also had the highest count of pathogenic SNPs 
known to cause XLA. 
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1 INTRODUCTION 
Till date, continuous effort is being channeled in several fields of biology, proteomic science, 
bioinformatics and other related fields to understand the fundamental relationship between 
the structure of a protein in relation to its functions. Earlier studies have been able to ascertain 
that conserved regions of protein structure and specific coverage of sequences or sequence 
profiles are directly linked to functional/active sites of a protein (Chen and Zhou, 2005). 
Bruton tyrosine kinase (BTK) is a cytoplasmic protein found in certain cells in the human body; it 
is responsible for B-lymphocyte development, differentiation, activation and signaling (Yu et al. 
2006). Although BTK is predominantly expressed in B lymphocytes, other subcellular locations 
of the BTK protein in humans include: cytoplasm, nucleus, plasma membrane and peripheral 
membrane protein; it is expressed in numerous tissues and the most abundant of these are the 
lymph, tonsil, blood, lymph nodes, bone marrow, spleen and connective tissues (Várnai et al. 
1999; Nore et al. 2000; Mohammed et al. 2000; Vargas et al 2002, Mohamed et al. 2009). 
The BTK protein contains five functional domains: Pleckstrin homology, Src homology 3, Src 
homology 2, Tyrosine kinase and Tec homology domains also written as PH, SH3, SH2, TK and 
TH respectively (Gustafsson et al. 2012).  These domain regions have been studied to exhibit 
high evolutionary conservation on both sequence level and structural level. Genetic variations 
in conserved residues are mostly responsible for various disease conditions (Chen and Zhou, 
2005). 
Genetic variations such as Single Nucleotide Polymorphisms (SNPs) have been observed to 
exhibit pathogenic phenotypes (Lindvall et al. 2005). A studied example of a pathogenic 
phenotype as a result of SNP in human BTK protein produces a disease condition known as X-
linked agammaglobulinemia (XLA), or Bruton agammaglobulinemia. 
According to Kang et al. (2001), 80% of XLA cases are usually as a result of a pathogenic 
variation in the human BTK gene which has been located at the long arm of the X chromosome 
at band Xq21.3 to Xq22. An on-going effort by Vihinen et al. (1998) and Väliaho et al. (2006) 
entails the meticulous curation of a registry specifically for XLA related variations which are as a 
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result of pathogenic SNPs associated with human BTK. This registry is publicly accessible as a 
database which can be found at: http://bioinf.uta.fi/BTKbase.  
Quite a number of biological activities are controlled or performed through interactions 
between proteins. Functionally important residues located at the surface of the protein serve 
as "interfaces" crucial for protein function. The interfacial contact or the characteristic of a 
protein interface has been defined by Chen and Zhou (2005) as "a pair of heavy atoms from two 
sides of a protein surface (interface)  that are  within 5 Å".  
The focus of this thesis work is to identify potential correlations between the results of 
independent research studies and web tools (on protein interface prediction) which have 
converging conclusions. Amongst these include: a meta-analysis of the human BTK protein 
surface using interface predictors to determine amino acid residues that are most likely 
situated in the interface region of the protein structure; identifying the secondary structures 
pertinent to be located at interfaces; to deduce the potential effects of known pathogenic SNPs 
that have been implicated in those interfaces. 
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2 THEORETICAL BACKGROUND 
2.1 Amino acid and Proteins 
Of all the biological molecules found in the human body proteins, in conjunction with other 
biomolecules, have been firmly accredited to be one of the most important of them all. Amino 
acids are sub units of proteins that ultimately form macro molecular structures through a series 
a biological processes. Structurally, these proteins are meticulously organized and fashioned in 
a step-wise manner through a series of electromagnetic interaction e.g. peptide bonds, 
disulphide and hydrogen and bonds.  
Proteomics and other molecular biosciences are continuously inventing a vast array of novel 
techniques to study amino acids, which serve as building blocks of proteins. Amino acids are 
divided into standard and non-standard; the standard amino acids comprise of twenty 
abundant residues with each having unique chemical structure and property (Anfinsen et al. 
1972). 
2.1.1 Amino acid: composition and property 
The standard twenty amino acids and their physiochemical properties that are of utmost 
interest in this particular work are shown in Figure 2.1.  
 
Figure 2.1 Hydrophobic chart of the standard amino acids (Monera et al. 1995) 
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Figure 2.2 Venn diagram classifying physical and chemical properties of standard amino 
acids (Taylor 1986; Luu et al. 2012) 
 
Table 2.1 The twenty standard amino acids with their corresponding chemical properties (Betts 
and Russell, 2003) 
Amino Acid 3-Letter code 1-Letter code Side-chain 
Polarity 
Side-chain 
charge 
Hydropathy 
Index 
Alanine Ala A Nonpolar Neutral 1.8 
Arginine Arg R Polar Positive -4.5 
Asparagine Asn N Polar Neutral -3.5 
Aspartic acid Asp D Polar Negative -3.5 
Cysteine Cys C Nonpolar Neutral 2.5 
Glutamic acid Glu E Polar Negative -3.5 
Glycine Gly G Nonpolar Neutral -0.4 
Glutamine Gln Q Polar Neutral -3.5 
Histidine His H Polar Positive -3.2 
Isoleucine Ile I Nonpolar Neutral 4.5 
Leucine Leu L Nonpolar Neutral 3.8 
Lysine Lys K Polar Positive -3.9 
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Methionine Met M Nonpolar Neutral 1.9 
Phenylalanine Phe F Nonpolar Neutral 2.8 
Proline Pro P Nonpolar Neutral -1.6 
Serine Ser S Polar Neutral -0.8 
Threonine Thr T Polar Neutral -0.7 
Tryptophan Trp W Nonpolar Neutral 0.9 
Tyrosine Tyr Y Polar Neutral -1.3 
Valine Val V Nonpolar Neutral 4.2 
 
 
2.2 Protein Structure Organization 
 Several levels of organization occur in proteins, and these are usually comprised of amino acid 
subunits conglomerated by chemical bonds. As shown in Figure 2.2,  Anfinsen et al. (1972) also 
deduced that the net physiological property of proteins are a function of the constituting amino 
acids.  
Protein structures exist in four levels of organization namely: primary, secondary, tertiary, and 
quaternary. Firstly, proteins are synthesized as a primary sequence (by the bonding of 
individual amino acid residues into a chain via peptide bonds) and then fold into secondary 
structures (alpha (α) helices and the beta (β) strands). Furthermore, the secondary structures  
fold into more complex form of polypeptides to form tertiary structures (including loops) and 
finally into quaternary structures- two or more polypeptides arranged in space in a specific 
orientation (Branden et al. 1997).  
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Figure 2.3 Image showing the hierarchical organization of protein structures (College of 
Siskiyous moodle: http://www.yellowtang.org/images/levels_of_protein_s_c_la_784.jpg, 2012) 
 
2.2.1 Factors Influencing Structures of Proteins 
Brooker et al. (2008) identified some factors that are pertinent to the structure of proteins. 
These factors consequently affect the folding of the protein structure as well as the stability: 
both have been shown to be major consequences of disease-causing amino acid substitution 
variation (Bross et al., 1999; Wang and Moult, 2001; Ferrer-Costa et al., 2002; Yue et al., 2005).  
Earlier studies by Thomas and John (1987) suggested that "the charge and charge distribution 
of proteins are likely to influence surface activity because it is known that most of the charged 
amino acids reside at the exterior of protein molecules". Below are factors influencing protein 
structures according to Brooker et al. (2008). 
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2.2.1.1 Hydrogen bond 
A high percentage of hydrogen bonds exist in protein: hydrogen bonding is the attraction of a 
hydrogen atom to an electronegative atom. Examples of electronegative atoms found in 
proteins include: nitrogen (N) and oxygen (O). Hydrogen bonds can occur in intramolecular or 
intermolecular forms. A collection of these bonds form substantial forces within the protein 
molecule. 
2.2.1.2 Disulfide bridges 
Disulfide bridges are formed when sulfhydryl groups from different amino acids bind to form a 
connection between the two amino acids. A sulfhydryl group consists of a sulfur atom 
combined with a hydrogen atom (–SH). According to Khan and Vihinen (2010), disulphide bonds 
contribute to the protein stability- they are usually formed by the bonding activity between 
sulfhydryl groups in cysteine molecules. 
2.2.1.3 Polar interactions 
Polar interactions are the attraction of negative side chains to positive side chains. Ionic 
bonding is a type of polar interaction. Ions are attracted to other ions of the opposite charge so 
the binding of the ions can result in a net charge of zero. Various amino acids have a net 
polarity (see Table 1) which is as a result of their side chains i.e. their R-group.  
2.2.1.4 Van der Waals forces 
Van der Waals forces are the weak attractions and repulsions of atoms. If an atom is within a 
certain distance of another atom, they will experience an attraction. If the atoms are too close, 
there will be a repulsion. 
2.2.1.5 Hydrophobicity 
Hydrophobic effect is the repulsion of nonpolar molecules from water, which is a polar 
substance. The nonpolar chains of a polypeptide move into the center of the structure away 
from the water and towards other nonpolar chains- this type of adaptive structures are called  
zwitterions. As shown above (see Figure 1), the level of hydrophobicity of each amino acids is 
peculiar to that amino acid.  
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Hydrophobic residues at interfaces tend to form clusters in comparison to non-hydrophobic 
residues (Neuvirth et al. 2004). In addition, interfacial sites tend to comprise of both 
hydrophobic residues and polar residues. These clusters account for the synergistic network of 
binding forces occurring at interfaces: both transient and obligatory interfaces. 
 
2.3 Protein Interfaces 
2.3.1 Protein Structural Organization and Conservation 
Amino acids are the building blocks of proteins (see Figure 2.3), several studies from various 
fields of proteomics, structural genomics and bioinformatics have published substantial 
scientific evidences of how protein structure (through conservation of amino acids) correlates 
strongly to protein function (Tsai et al. 1996; Vihinen et al. 2000; Neuvirth et al. 2004; Keskin 
and Nussinov 2005; Liang et al. 2006; Porollo and Meller 2007; Khan and Vihinen, 2010).  
Only some parts of the entire protein surface are actively involved in biological processes; they 
are known to be functionally active sites by interacting with other molecules including other 
proteins. Evolutionarily important residues are most probable to be found at interfaces, and 
these have a high potential to be conserved as well (Chen and Zhou, 2005). In previous studies 
(Armon et al. 2001; Landgraf et al. 2001; Lichtarge and Sowa, 2002), conservation of residues at 
interfaces was a key criteria in predicting "hot spot residues" that are involved in protein-
protein interactions. These residues were observed to be more conserved than other surface 
residues (Liang et al. 2006). 
2.3.2 Protein Surface and Protein Interface 
Protein interactions are pivotal to the optimal function of every protein- a concept that is 
continuously being researched especially with the exponential technological advancement in 
fields such as structural genomics (Zhou and Qin, 2007). Several research groups and institutes 
have developed bioanalytical web servers and/or stand-alone software installations that assist 
in predicting interface residues for any given protein (Chen and Zhou, 2005; Liang et al., 2006; 
Porollo and Meller, 2007; Qin and Zhou, 2007) 
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Following the first successful automated method by Zhou and Shan (2001) that was tailored to 
predict interface residues in protein-protein complexes, immense efforts has been channeled in 
exploring the possibilities such methods provide. In 2004, Neuvirth et al. suggested that protein 
interaction does not occur throughout the entire surface of a protein but only in a few parts, 
and these few interacting surfaces of the protein share common physiochemical properties. 
Porollo and Meller (2007) further developed a method to predict interface residues using 
relative solvent accessibility (RSA) as the basis of the algorithm. The RSA-based prediction 
method further differentiated between interacting and non-interacting residues on protein 
surfaces.  
 
2.3.3 Definitions for Interaction Site / Interface 
The definition for an "interaction site" stems from the method of prediction specified in the 
algorithm used for that prediction. Porollo and Meller's (2007) method of RSA defined an 
interaction site as "the difference between unbound and bound (complex) structure of an 
individual chain". This can be simplified as: computing the difference between the values of (a) 
the exposure of an amino acid residue before binding with another molecule and (b) its 
exposure after it has form a complex upon binding. Noticeably, the former value should be 
higher than the latter for those residues predicted to be found in interfaces.  
Using a consensus neural network based on sequence profiles and solvent accessibility, Chen 
and Zhou (2005) designed a method for the prediction of interface residues between protein-
protein complexes; they established a definition for interfacial contact between protein 
complexes derived from PDB to be: "a pair of heavy atoms from two sides of an interface that 
are within 5 Å".  
Generally, protein-protein interface predictors have one or more of the following definitions for 
interfaces which are based upon: 
1. The relative distance between the van der Waals surfaces of the atoms in partner chains 
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2. The relative distances between the centers of the atoms in different protein chains 
3. The relative distance between alpha carbon atoms in protein chains (Jordan et al. 2012) 
 
2.3.4 Types of Protein-Protein Interfaces 
An extensive analysis carried out at the Columbia University, NY by Ofran and Rust (2003) 
enumerated six significant types of protein-protein interfaces using just sequence features of 
the proteins. They were classified in the following category: 
 Intra-domain: interfaces within one structural domain 
 Domain–domain: interfaces between different domains within one chain  
 Homo-obligomer: interfaces between permanently interacting identical chains 
 Homo-complex: interfaces between transiently interacting identical protein chains 
 Hetero-obligomer: interfaces between permanently interacting different protein chains 
 Hetero-complex: interfaces between different transiently interacting protein chains  
The term "obligomer" refers to "interfaces between residues from two chains that are 
obligatory" (Ofran and Rust, 2003). 
 
2.3.5 Characteristics of Protein Interface Residues 
Irrespective of the methods used for prediction of interface residues, the result of most method 
predict similar "hot spot" residues for the same protein. This unison-like results from various 
prediction methods are mostly due to the physiochemical properties common to interface 
residues (Zhou and Qin, 2007) or at the interface itself.  
Currently, emerging prediction methods combine various prediction algorithms in other to 
increase the accuracy of prediction (Qin and Zhou, 2007). The most eminent characteristics of 
protein interfaces and/ interface residues include: 
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.3.5.1 Solvent accessibility: 
 Porollo and Meller (2007); Chen and Zhou (2005) ascertained that interface residues have 
higher solvent accessibility than non-interface residues. Since non-interface residues do not 
form complexes with other external molecules, they tend to be buried further in the protein 
structure where they exert more intra-molecular interactions. Thus, having lesser accessibility 
to the surface of the protein (Jones and Thornton, 1996; Zhou and Qin, 2007; ).  
2.3.5.2 Sequence Conservation:  
In comparison to non-interface residues, residues found at interfaces are evolutionarily 
conserved (Liang et al., 2007). Some of the prediction methods utilize this property when 
designing their algorithm or during data training of neural networks to set certain parameters 
e.g. sequence coverage (Chen and Zhou, 2005).  
2.3.5.3 Distribution of amino acids:  
Certain studies have observed that some amino acids, especially arginine are more abundant at 
protein interfaces than others (Zhou and Shan, 2001). Crowley and Golovin (2005) attributed 
this richness in arginine at protein interfaces to cation-π interactions. 
2.3.5.4 Chemical Properties:  
Protein interfaces have been observed to be predominantly hydrophobic (see Figure 1) - as a 
result of abundant hydrophobic amino acid residues located at interfaces (Neuvirth et al. 2004). 
In addition, the evolutionarily active residue positions "hot spots", are oftentimes conserved 
and conflicting reports suggest that they are composed of polar and/or non polar residues (see 
Figure 2) (Zhou and Shan, 2001; Hu et al., 2000; Glaser et al., 2001; De Lano, 2002; ) except for 
arginine (Zhou and Shan, 2001). Also, the analysis of Chen and Zhou (2005) showed that non 
polar as well as charged residues were more favored in interfaces. The non polar residues 
observed to be abundant include: leucine, isoleucine, phenylalanine, tyrosine valine and 
methionine. 
2.3.5.5 Structural Properties:  
Structurally significant observations regarding interfaces suggests that they frequently appear 
in between domains, in large proteins (Jones and Thornton, 1997; Lo Conte et al., 1999; Ma et 
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al., 2002). Interfaces are usually circular (Kleanthous, 2000) and loops are often present at the 
edges of interfaces, contributing about 40% of interfacial contacts (Miller, 1989).  
Additionally, Neuvirth et al. (2004) discovered from their analysis that β-strands are more 
favored than α-helices at interfaces. It was suggested that the flat surfaces of β-strands appears 
to form a favorable three-dimensional binding opportunity at interfaces in comparison to the 
cylindrical surface of α-helices. 
2.3.5.6 Forces at interfaces:  
Many hydrophobic and electrostatic interactions at interfaces are known to occur by the means 
of hydrogen bonds; due to the nature of transient complexes, hydrogen bonds are suggested to 
be more abundant, accounting for the occurrence of a weak affinity (Jones and Thornton 1995; 
Lijnzaad and Argos, 1997).  
Salt and disulphide bridges have been observed to be present at interfaces. Even though they 
are rare, disulphide bonds appear to have a large stabilizing effect when they occur at 
interfaces (Neuvirth et al., 2004).  
2.3.5.7 Interface residue-energy distribution:  
Previous efforts to identify interface residues involved the analysis of entropic activity of 
interface residues. Researchers such as Elcock (2001), predicted interface residues by analyzing 
their high electrostatic energy. Others explored the differences in free-energy of amino acids to 
identify interface residues (Cheng et al. 2005).  
 
2.3.6 Types of Complexes at Interaction Sites 
In 2007, Porollo and Meller suggested that various complexes of proteins maybe involved in 
several interactions that occur at interface regions. Earlier studies in structural genomics 
proposed the various types of complexes formed by protein interaction. They include but are 
not limited to: transient versus obligatory complexes, homodimers versus heterodimers, 
enzyme binding complexes versus other complexes,  (Jones and Thornton, 1996; Jones and 
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Thornton, 1997; Hu et al., 2000; Glaser et al., 2001; Zhou and Shan, 2001; Ofran and Rost, 
2003).  
 
 
2.4 Human Bruton Tyrosine Kinase (BTK) Protein 
The BTK protein has been identified in about sixty species, and it is most predominant in 
mammals (Hubbard et al., 2007). In humans, BTK -an enzymatic cytoplasmic protein, is usually 
expressed in cells of the immune system. BTK in humans is responsible for B-lymphocyte 
development, differentiation, activation and signaling (Yu et al. 2006).  
The subcellular location of the BTK protein in humans include: cytoplasm, nucleus, plasma 
membrane and peripheral membrane protein; it is expressed in numerous tissues and the most 
abundant of these are the lymph, tonsil, blood, lymph nodes, bone marrow, spleen and 
connective tissues (Várnai et al. 1999; Nore et al. 2000; Mohammed et al. 2000; Vargas et al 
2002). In addition, BTK is known to be expressed in hematopoietic cells, excluding T 
lymphocytes and terminally differentiated plasma cells (Smith et al., 1995). 
The gene coding for BTK in humans is known to span over 36 kb and is composed of 19 exons 
(Sideras et al., 1994).  Vetrie et al. (1993) described the complete nucleotide sequence of the 
mRNA (cDNA) encoded by human BTK to be having 659 amino acids. 
 
2.4.1 BTK Domains and Interaction 
 BTK protein has five functional domains: The end terminal Pleckstrin homology, Src homology 
3, Src homology 2, Tyrosine kinase and Tec homology domains also known as PH, SH3, SH2, TK 
and TH respectively (Vihinen et al. 1994; Smith et al. 1994; Gustafsson et al. 2012). These 
domain regions have been studied to exhibit high evolutionary conservation on both sequence 
level and structural level (Thusberg and Vihinen, 2009). 
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2.4.1.1 PH Domain  
(Pleckstrin homology domain): PH domains are the 11th most common domain in the human 
genome (Lemmon, 2007). In reference to Haslam et al. (1993) and Mayer et al. (1993), it derives 
its name as a result of the sequence elements found to be repeated in both the N-terminal and 
C-terminals of pleckstrin.  
"Pleckstrin", the protein where the PH domain was first detected, is a major substrate for 
protein kinase C in platelets and leukocytes (Jackson et al. 2011). PH domains consist of 
approximately 120 residues (Vihinen et al., 1994) and although there is little conservation 
among PH protein families, their tertiary structure is quite similar consisting of a conserved of a 
β-barrel composed of two perpendicular anti-parallel β-sheets followed by a C-terminal 
amphipathic helix (Ferguson et al. 1995; Saraste and Hyvönen, 1995).  
Functionally, PH domain is known to aid in the activation of the catalytic transphosphorylation 
of  the BTK protein (Li et al., 1997) by the binding to end products of phosphatidylinositol 3-
kinase (PI 3-kinase) family which includes phosphatidylinositol 3,4,5-trisphosphate (Salim et al., 
1996; Rameh et al., 1997) and inositol 3-phosphates (Fakuda et al., 1996).  
Earlier studies (Ferguson et al., 1995; Fakuda et al., 1996; Salim et al., 1996; Rameh et al. 1997) 
using computer-generated models suggested that residues located in protein-protein interfaces 
which are essential for the binding of these lipid molecules within the BTK PH domain includes 
L12, F25, and R28. 
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Figure 2.4 A structure from PDB (1BTK) showing PH domain and BTK motif from human 
Bruton tyrosine kinase protein; included is the position of the mutant arginine residue (R28C), 
associated with XLA in humans (Hyvönen and Saraste, 1997). The ball representations in the 
structure denotes the positions of the mutant residue R28C in both chains of the molecule. 
 
2.4.1.2 SH2 and SH3 Domains 
The Src homology (SH), a region of homology between two tyrosine kinases that lay outside the 
catalytic domain, was discovered by Pawson's group in 1986 and termed SH2 and SH3 based on 
the variety of proteins they contain and their respective catalytic activity (Mayer and Baltimore, 
1993). Cytoplasmic proteins containing SH domains are known to be involved in signal 
transduction (Mayer, 2001) and they also appear to mediate controlled protein-protein 
interactions  (Mayer and Baltimore, 1993). 
SH3 
In BTK protein, sequence annotation suggests that the SH3 domain proceeds the SH2, and this 
order is also reflected in the catalytic activity of both domains (Mayer and Baltimore, 1993). 
SH3 is a small domain of about 60 amino acid residues that is present in a large number of 
eukaryotic proteins (Musacchio et al. 1992); they have a moderate affinity and specificity for 
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proline-rich ligands that affects myriads of biological processes ranging from regulation of 
enzymes by intra-molecular interactions, increasing the local concentration or altering the 
subcellular localization of components of signaling pathways to mediating the assembly of large 
multi-protein complexes (Mayer, 2001).  SH3 domain belong to the class of Pro-rich binding 
domains (Gushchina et al. 2011).  
Structurally, the basic fold of many SH3 domains contains five anti-parallel beta-stands that are 
closely packed to form two perpendicular beta-sheets. The ligand-binding site consists of a 
hydrophobic patch that contains a cluster of conserved aromatic residues and is surrounded by 
two charged and variable loops; SH3 domains bind to Pro-rich peptides that form a left-handed 
polyPro type II helix, with the minimal consensus Pro-X-X-Pro (Gushchina et al., 2011). Each Pro 
is usually preceded by an aliphatic residue. Each of these aliphatic-Pro pairs binds to a 
hydrophobic pocket on the SH3 domain (Nguyen et al., 1998; Gushchina et al., 2011).  
Okoh and Vihinen (2002) established an association between the SH3 and TH domains in BTK 
which occurs in a regulative fashion. In another study by Patel et al (1997), a point amino acid 
variation that led to the deletion of 14 amino acids at the terminal end of the SH3 domain was 
observed in a patient with XLA. They suggested that the consequence of such variation led to 
reduction in the binding activity between SH3 and TH domains. Thus, a probable etiology for 
the XLA in the patient being studied. 
SH2 
In respect to domain class, SH2 belongs to the Phospho-Tyr binding domains that function as 
regulatory modules of intracellular signaling cascades by interacting with phosphotyrosine-
containing peptides and proteins, and are usually composed of approximately 100 amino acids 
(Bibbins et al., 1993). Vihinen et al., (1996); Vihinen et al., (1997); Vihinen et al., (1999)  showed 
that pathogenic variations in the SH2 domain of BTK are associated with impaired B cell 
function and this may result in the XLA immunodeficiency in humans, as a result of a disruption 
in the phosphotyrosine binding sites. In one study by Tzeng et al., (2000) the BTK SH2 domain 
was found to be essential for phospholipase C-γ phosphorylation by the interaction of B-cell 
linker protein (BLNK), and variations in the SH2 domain were shown to cause XLA.  
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Structure-wise, SH2 domains typically contain a central anti-parallel beta sheet that is 
surrounded by two α-helices; the loop between the second and third β-strands  provides many 
of the binding interactions with the phosphate group of its phosphopeptide ligand (Pawson et 
al., 2002). According to studies by Waksman et al., (1992) "conserved residues contribute to the 
hydrophobic core or are involved in pY (phosphorylated Tyrosine) recognition while more 
variable residues contribute to specific recognition of C-terminal residues". Furthermore, "an 
invariant arginine residue in the SH2 domain coordinates the phosphate oxygens of pY and is 
essential for high affinity phosphopeptide binding". 
 
(a)  (b)    
Figure 2.5 (a) Cartoon structure (PDB:1AWX) by Hansson et al. (1998) showing the anti-
parallel beta-stands of SH3 domain from human BTK protein. Patel et al (1997) suggested that 
the C-terminal end of the domain is responsible for its binding activity with TH domain within 
the same BTK protein. (b) SH2 domain structure (Huang et al, 2006) of human BTK protein 
showing anti-parallel beta-stands flanked by two α-helices. Its side chains are responsible for 
interactions with phosphotyrosine-containing peptides. 
The sequence annotation of the human BTK protein and available structures have been 
tabularized below. Some of the domains were observed to have more than one solution 
structure in the PDB database. 
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Table 2.2 Sequence annotation of human BTK protein showing various regions (The 
UniProt Consortium, 2012). Representative structures derived from RCSB PDB (Berman et 
al.2000) are also included in the table. 
Regions Residues Length Description Pdb_id 
Domain 3 – 133 131 PH 
1BTK 
(1.60) 
Domain 214 – 274 61 SH3 
1AWX 
(NMR) 
Domain 281 – 377 97 SH2 2GE9 
Domain 402 – 655 254 Tyrosine kinase 
3P08 
(1.50), 
Zinc finger 135 – 171 37 Btk-type  
Nucleotide 
binding 408 – 416 9 ATP  
Region  12 – 24 13 
Inositol-(1,3,4,5)-
tetrakisphosphate 1-
binding  
Region 474 – 479 6 Inhibitor-binding  
Motif 581 – 588 8 CAV1-binding  
 
Table 2.3 Domain wise categorization of  BTK family kinases protein interactions 
DOMAIN  DOMAIN DESCRIPTION INTERACTING PATNERS 
PH and TH 
 Multifunctional domain assumed 
to bind to phospholipids 
 The interaction during signal 
transduction is likely to be 
transient and dynamic 
 Linked to XLA (Rawlings et al., 
1993; Thomas et al., 1993) 
1. Phosphoinositides 
2. heterotrimeric G-protein subunits 
3. F-actin 
4. PKC isoforms 
5. BP-135/TFII-I 
6. STATs 
7. FAK 
8. Fas 
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9. PTPD1 
SH3 
 It recognizes proline-rich motifs 
in many proteins 
 Regulates BTK via binding to 
regulatory proteins or internal 
folding 
 So far, no pathogenic SNPs 
leading to XLA has been found 
1. CD 28 
2. c-Cbl  
3. WASP 
4. ZAP-70 
SH2 
 Recognizes phosphotyrosine 
containing peptides and proteins  
 Linked to XLA (Vihinen et al. 
1999) 
1. Vav 
2. BLNK 
3. Dok-1 
 
Kinase 
 Highly conserved domain (Qiu et 
al. 1998b) 
 Involved in regulation  
1. BRDG1 
2. PI3K 
3. GRB10 
 
Other examples of interacting partners with human BTK include: 
CD4:  T-cell surface antigen T4/Leu3 (Wang, 2004) 
CD34: Hematopoietic progenitor cell antigen CD34 precursor (Meffre et al., 1997) 
HCPH: Hematopoietic cell protein-tyrosine phosphatase (KEGG pathway: hsa04662) 
LYN: Tyrosine-protein kinase (KEGG pathway: hsa04662, hsa04664) 
BAD: Bcl2 antagonist of cell death (Ottilieet al., 1997; Danial, 2003) 
HCK: Hemopoietic cell kinase (Cheng et al., 1994) 
RAG2: Recombination-activating protein 2 (Kouro et al., 2001) 
RAL: Ral-A precursor (de Gorter et al., 2008) 
LCP2: Lymphocyte cytosolic protein 2 (Liu et al., 2006) 
CD22: B-cell receptor CD22 precursor (Moschese et al., 2004) 
GTF2I: General transcription factor II-I (Sacristán et al., 2004) 
DRP2: Dihydropyrimidinase-related protein 2 (Sedivá et al., 2007) 
IGB: Immunoglobulin beta (Lougaris et al., 2008) 
GP6: Glycoprotein VI (platelet precursor) (Yi et al., 2005) 
BCM: B-cell maturation protein (Jin et al., 2008) 
Sab: SH3-domain binding protein 5 (BTK associated) (Yamadori et al., 1999) 
Ly49: Killer cell lectin-like receptor subfamily A, member 1 (Mestas and Hughes, 2004) 
PLCG1: Phospholipase C-gamma-1 (KEGG pathway: hsa04664) 
SPNS1: Sphingolipid transporter 
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FKBP4: FK506 binding protein 4  
CD164: Putative mucin protein precursor 24 (Kneidinger et al., 2008) 
PLCG2: Phospholipase C-gamma-2 (KEGG pathway: hsa04662) 
ACTL6B: Actin-like protein 6B  
PRDM1: PR domain zinc finger protein 1 (Takatsu et al., 2004) 
PIK3R5: Phosphoinositide 3-kinase regulatory subunit 5 (KEGG pathway: hsa04664) 
RPS6KB2: Ribosomal protein S6 kinase, 70kDa, polypeptide 2 
KHDRBS1: KH domain-containing, RNA-binding, signal transduction-associated protein 1 
 (Guinmard et al., 1997) 
TNFRSF10D: Tumor necrosis factor receptor superfamily member 10D precursor (Bouralexis et 
 al., 2003) 
 
Figure 2.5 Annotated domains of the BTK and interacting partners (Mohamed et al., 2009) 
 
 2.5 Human BTK and X-linked agammaglobulinemia (XLA) 
BTK is an highly conserved cellular protein, variations in functionally known conserved residues 
are mostly responsible for disease conditions as observed in XLA (Chen and Zhou, 2005). It 
belongs to the Tec family of protein tyrosine kinases (PTKs) and it is involved with many crucial 
cellular processes; pathogenic variations affecting BTK results in developmental deformities in 
the maturation  of B-lymphocytes. 
X chromosome-linked (alternatively X-linked) agammaglobulinemia, generally known as Bruton 
agammaglobulinemia (Bruton, 1952), is a severe disease condition characterized by failure in 
normal maturation of the B lymphocytes. It is associated with pathogenic variations in the gene 
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coding for BTK (Lindvall et al. 2005). Statistically, XLA has an average frequency of 1/150,000 
male births in humans (Smith et al., 1995).  
From the serology outlook, individuals with XLA generally have low serum immunoglobulin and 
(Campana et al., 1990) are unable to produce adequately crucial components of the immune 
system- the immunoglobulins (Conley et al., 1986). Consequently, such individuals with this 
type of compromised immune system have been observed to having increased susceptibility to 
certain microbial infections: both bacterial (Lederman and Winkelstein, 1985) and Enterovirus 
species infections (McKinney et al., 1987). 
 
 
2.6 Genetic Variation: Polymorphism in BTK 
Genetic variations such as Single Nucleotide Polymorphisms (SNPs) result into non-synonymous 
SNPS (nsSNPs) pathogenic SNPs, otherwise known as disease-causing variations (Cargill et al., 
1999; Halushka et al., 1999). The occurrence of pathogenic SNPs has been observed to affect 
the function of a protein after post-translational modifications (Lindvall et al. 2005; Thusberg 
and Vihinen, 2009). 
The prevalence of pathogenic SNPs during protein transcriptional processes such as the 
formation of pre m-RNA, mRNA splicing, mRNA stability and alternative splicing (Thusberg and 
Vihinen, 2009), have been observed to account for less than 10% of all nsSNPs cases (Stenson et 
al., 2003). 
Although the precise mechanism of action of some of these pathogenic SNPs have not been 
fully understood, amongst many, XLA (X chromosome-linked agammaglobulinemia) is as a 
result of pathogenic SNPs occurring in the gene coding for human BTK protein (Lindvall et al. 
2005).  
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2.7 Application of Protein-Protein Interface Predictions 
Protein interactions form the core of understanding the diverse functions of several 
biomolecules, and various methodologies of predicting interfacial regions of proteins have  
various applications in the field of molecular science, especially proteomics. Knowledge from 
protein interface prediction can be applied to solve problems in certain areas such as binding 
and docking site predictability, protein-protein interface regions etc. 
 
2.7.1 Functional Sites 
The binding activity occurring at interaction sites of proteins mostly suggest that they are the 
functional parts of the molecules. Algorithms that are used in the prediction of functional sites 
mostly emphasize evolutionary relations as seen in phylogenetic trees (Landau et al., 2005). In 
addition of evolutionary relations, the physiochemical and structural properties of residues 
amplifies the accuracy of functional site prediction (Zhou and Qin, 2007). As seen in BTK, 
pathogenic variations are known to occur in protein interfaces (Zhou, 2004; Brautigam et al., 
2006) and computational prediction of interfaces can help understand the disease mechanisms 
and subsequent design of therapeutic agents (Zhou and Qin, 2007). 
 
2.7.2 Docking Sites 
Qin and Zhou (2007) defined docking as "the procedure by which the structure of a protein 
complex is built from the unbound structures of the subunits". The process of docking presents 
a complication in identifying which sets of subunits fits and how to rank accurately the lists of 
probable sets. Protein-protein interface prediction helps to alleviate the problems arising from 
conformational changes that occur during the docking process: commonly referred to as the 
front end use (Zhou and Qin, 2007; Qin and Zhou, 2007b). Protein-protein interface predictions 
are first used to determine if two protein molecules interact, subsequently, docking predictions 
are employed to determine which regions of the molecules interact what type of interaction 
takes place- obligate or non-obligate; transient or obligatory (Li and Kihara, 2012).  
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2.7.3 DNA-binding Sites 
The underlying rationale that guides the prediction of protein-protein interfaces has been 
utilized to predict DNA-binding sites on proteins that interact with DNA (Zhou and Qin, 2007). 
Earlier studies have utilized e.g. the neural network method (Ahmad et al., 2004; Tjong and 
Zhou 2007) to address the prediction of DNA-binding sites on proteins with much success. 
Although similar in rationale, the non-DNA contacting regions of a protein can be distinguished 
from DNA-binding sites by peculiar characteristics- DNA-binding sites are enriched in positively 
charged Arg (R) and Lys (K) residues and depleted in negatively charged Asp (D) and Glu (E) 
residues (Zhou and Qin, 2007). 
 
2.7.4 Drug discovery and design 
Experimental methods have been used in times past to identify therapeutic substances from 
various sources including microorganisms e.g. penicillin from Penicillium fungi. The use of 
protein-protein interface prediction technologies enables the specification of vital components 
of organism's interactome that requires further research (Fuentes et al., 2009). The knowledge 
of protein-protein interface networks empowers pharmaceutical proteomists to distinguish 
which protein-protein interaction network an upcoming therapeutic agent should be targeted; 
the optimal design such agent would best deliver the intended therapeutic effect (Grosdidier et 
al., 2009).  
 
2.7.5 Etiology of Diseases 
Several diseases of genetic origin are consequences of miscommunication between protein-
protein interactions at genomic level. In a recent article by Hosur et al. (2011), a protein-protein 
interface predictor (iWRAP) was designed and tested on set of yeast genes that were related to 
cancer. This dataset of disease genes were derived from the CYGD by Güldener et al., (2005). 
iWRAP successfully identified peculiar genes that were subjected to further experimental study 
(Hosur et al., 2011) 
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3 STUDY OBJECTIVES 
The meta-analysis of the interface region of human BTK protein with respect to known disease-
causing SNPs was performed with the following aims and objectives:  
1. To classify the RSA of pathogenic SNPs associated with human BTK using various single and 
meta-web servers . 
2. To assess variation "hotspots" in human BTK domains. 
3. To map predicted pathogenic SNPs in relation to their interfacial locations on the domains of 
human BTK protein. 
4. To analyze the possible implications of pathogenic variations situated at the BTK protein 
interface. 
5. To statistically compute the abundance of each of the twenty amino acids across the 
predicted interface regions of human BTK domains. 
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4 MATERIALS AND METHODS 
4.1 Dataset of Missense Variations (SNPs) 
Approximately 80% of patients suffering from agammaglobulinemia have a pathogenic 
variation in the gene coding for human BTK protein (Vihinen et al., 1999). A set of data 
containing pathogenic amino acid substitutions in human BTK protein and their corresponding 
domains was obtained from BTKbase: http://bioinf.uta.fi/BTKbase/?content=pub/IDbases 
(August, 2012).  
The BTKbase is a publicly available biological database that continuously curates clinical cases of 
agammaglobulinemia (Vihinen et al, 1998; Vihinen et al. 1999; Väliaho et al. 2006) and is 
continuously maintained (Version 8.52, last update: 16th June, 2011) by the bioinformatics 
group at the Institute of Biomedical Technology (IBT), University of Tampere, Finland. The 
webpage is available at: http://bioinf.uta.fi/BTKbase/ 
The dataset considered for analysis contained 560 amino acid substitutions (pathogenic SNPs) 
which included: 105 entries for PH domain, 11 entries for the Zinc finger region, 106 entries for 
SH2 and 338 entries for the kinase domain. Apart from entries for zinc finger region, all other 
entries were used in the domain-wise analysis of protein interfaces in the human BTK. As of the 
time of this analysis (August 2012), there is no known pathogenic amino acid substitution  that 
causes XLA in the SH3 domain of human BTK protein.  
From the BTKbase data, it was observed that missense variations caused by single nucleotide 
substitutions signified that it contained a limited subset amino acid changes (i.e. given the 
physiochemical properties of amino acids, every residue at each position cannot change to all 
other 19 residues). There were however, multiple entries for few amino acid residue positions 
that subsequently suggests the possibility that those positions are 'hotspots'- amino acid 
positions more susceptible to variation. Table 8.4 in the appendix shows the raw datasets 
grouped according to domain.  
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4.2 Sequences and Structures 
In order to understand the level of variation in the dataset, reference sequences for the BTK 
domains and the human BTK protein were obtained from NCBI's RefSeq database (except for 
SH3 domain because currently, as at the time of this thesis work, there are no known amino 
acid substitution leading to Agammaglobulinemia) and EMBL-EBI's Uniprot database (The 
UniProt Consortium, 2012). The sequence ontology feature at Uniprot was used to understand 
the boarders of each domain and classify them accordingly- PH, SH2, Kinase domains. 
For the analysis and rendering of the results into structural presentation, the VMD (Visual 
Molecular Dynamics) standalone software by the Theoretical and Computational Biophysics 
Group at the University of Illinois, was used. According to Humphrey et al. (1996), VMD is "a 
molecular visualization program for displaying, animating, and analyzing large biomolecular 
systems using 3-D graphics and built-in scripting". It is a free computer software program that is 
available on major computer platforms. The VMD home page is available at: 
http://www.ks.uiuc.edu/Research/vmd/ 
Similarly, through the process of querying the RCSB PDB (Protein Data Bank) (Berman et al., 
2000) database with the molecule name- human BTK, structures of PH, SH2 and Kinase domain 
were obtained. Although there were more than one entry for some of the domains, careful 
selection was done to obtain the best candidate structure. The selection was done based on the 
following criteria: 
 
4.2.1 The Experimental Source of the Structure 
The methods used to obtain the protein tertiary 3D structure are namely: X-ray crystallography, 
NMR spectroscopy or electron microscopy (Berman et al., 2000). At the time of this thesis work, 
there were over 70,000 protein structures solved by X-ray method and just under 10,000 
structures solved by NMR method. The source of the structure was considered as a criteria for 
selection because a few of the protein interface predictors performed poorly (incomplete 
prediction e.g. PPI-Pred) with protein structures derived from NMR method when compared to 
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those derived through X-ray method. This was as a result of incompatibility of the NMR data file 
with the algorithm of the web server.  
 
4.2.2 The Resolution [Å] of the Structure 
The X-ray method was preferred due to the favorable data structure of the pdb file. Also, with 
the X-ray data, the resolution [Å] of the candidate protein structure is indicated.  The structures 
of PH (1BTK, 1.6 Å) and Kinase (1K2P, 2.10 Å) domains were derived from X-ray while that of 
SH2 (2GE9) was from NMR.  
 
4.2.3 The Amount of Chains in the structure 
The solution structure of the BTK domains are available in 3D the quaternary structure from 
PDB database. Since most of the interface predictors needed chain specificity, the nature 
(identical or not) of the chains and amount were used as another criterion for the selection of a 
candidate structure. The structures of PH and Kinase domain have two identical chains (A and 
B), in which chain A was used for the analysis. For the SH2 domain structure, it had only one 
chain which consequently reduced the ambiguity of chain selection. 
 
 
4.3 Selection of Interface Predictors 
With the emergence of various methods for protein interface predictions, a brief review by 
Zhou and Qin (2007) of some of the key aspects of protein interface prediction listed some 
elements one needs to consider while selecting an interface predictor. Some of them include: 
the characteristics of interface residues (such as sequence conservation, secondary structure, 
solvent accessibility etc.) and methods of interface prediction (scoring function and neural 
network, support vector machine etc.).  
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Six protein-protein interface predictors were selected for this thesis work using the above listed 
criteria in section 4.2.  Additionally, the simplicity of the web server's interface; the web 
server's processing and downtime; the structure and format of the prediction results, were also 
used to for the selection.  
The selected predictors include: cons-PPISP (Chen and Zhou, 2005), PredUS (Zhang et al. 2010), 
SPPIDER (Porollo and Meller, 2007), Meta-PPISP (Qin and Zhou, 2007), PPI-Pred (Bradford and 
Westhead, 2004) and PIER (Kufareva et al. 2007). In other to create congruence in the analysis, 
these chosen predictors use different algorithms of prediction.  
 
4.3.1 Cons-PPISP (Consensus Protein-Protein Interaction Site Predictor) 
Cons-PPISP is a consensus neural-network protein-protein interaction site predictor that was 
developed by the Zhou group at Florida State University (FSU). The input is the unbound 
structure of a protein, which is known to bind another protein. It utilizes a trained neural 
network algorithm to predict which residues will most likely form the binding site for another 
protein (Zhou and Shan, 2001; Chen and Zhou, 2005). This predictor was selected because the 
best available structure of the SH2 domain obtained from the PDB database was derived 
through NMR method. From an earlier research by Chen and Zhou (2005), they reported that 
cons-PPISP was a fitting predictor for analyzing structures with NMR data. The web server can 
be located at: http://pipe.scs.fsu.edu/ppisp/ 
 
4.3.2 PredUS (Prediction of Protein Interfaces Using Structural Alignment) 
PredUS is an interactive web server for prediction protein-protein interfaces through a support 
vector machine prediction method. According to Zhang et al. (2011), "potential interfacial 
residues for a query protein are identified by 'mapping' contacts from known interfaces of the 
query protein's structural neighbors to surface residues of the query". In other words, 
interfacial residues from all known complexes of the query protein and its structural neighbors 
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are sequentially scored and mapped to the query structure. As an example, the image below is 
a query result generated from the analysis of the PH domain using the PredUS web server. 
 
Figure 4.1 An image from PredUS result showing a contact (heat) map of predicted interfacial 
residues. The higher the residue (contact) score, the darker the shade of red.  
Besides the interactive graphical "contact (heat) map" it produces as a result from the query, 
another reason it was chosen was because of the simplicity of the user interface that is 
available at: http://bhapp.c2b2.columbia.edu/PredUs/. As an additional feature, the possibility 
of refining the results of a prediction can be achieved if the user specifies which neighboring 
structures should be used for contact scoring of the residues in the query protein. 
 
4.3.3 SPPIDER (Solvent accessibility-based Protein-Protein Interface iDEntification and 
Recognition) 
Jarek Meller's bioinformatics group, of the University of Cincinnati, maintains a web server- 
SPPIDER (http://sppider.cchmc.org/) that recognizes protein-protein interaction sites through a 
consensus classifier. The SPPIDER is available in two options: (a) prediction of potential protein-
protein interfacial residues (using one protein chain as the query protein) and (b) identification 
of protein interface with protein-protein complex (The query structure is a complex structure 
containing more than one protein). The algorithm of the consensus classifier uses relative 
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solvent accessibility (RSA)-based fingerprint to significantly distinguish between the interacting 
and non-interacting sites of the query protein (Porollo and Meller, 2007). This method claimed 
to dramatically improve the accuracy of prediction up to 70%.  
 
4.3.4 Meta-PPISP (Meta Server for Protein-Protein Interaction Site Prediction) 
Also from the Zhou group, meta-PPISP is a bioinformatics web tool designed as a meta server 
that is made up from the combination of three individual web servers: cons-PPISP, PINUP, and 
Promate. As one would expect, a cross validation of this meta server against the individual 
servers showed that it has an improved accuracy and coverage (Qin and Zhou, 2007).  
Although it is a structure based predictor, it uses linear regression method to compute the 
scores from the three servers (cons-PPISP, Promate and PINUP) and uses it as an input. It 
further correlates individual scores for each residue through a series of optimization to produce 
a final prediction. The result of the meta-PPISP is tabulated and it also includes those from the 
constituent servers. Meta-PPISP was chosen because of the meta-method it utilizes in its 
prediction and it is freely available at http://pipe.scs.fsu.edu/meta-ppisp/ 
 
4.3.5 PPI-Pred (Protein - Protein Interface Prediction) 
This simple web server utilizes a combination of support vector machine and surface patch 
analysis for predicting probable protein-protein interfacial residues (Bradford and Westhead, 
2005). With its simple user interface, it gives four options for viewing the results of a prediction 
set: (a) a simple tabular listing of predicted highest scoring residue patches or (b) a color-coded 
sequence view showing predicted residues according to scoring patches or (c) a modified pdb 
file that shows the predicted residues in colors or (d) a surface view that shows the location of 
the three patches on the surface using Pred-viewer. The open-access web server is available at 
http://bmbpcu36.leeds.ac.uk/ppi_pred/index.html  
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4.3.6 PIER (Protein IntErface Recognition) 
This predictor by far had the simplest user interface (Pdb code/file and Chain) and it was the 
fastest amongst all the protein-protein interface predictors. This predictor has a net prediction 
accuracy of 60%  and also utilizes the patch generation algorithm. In addition to that, it 
inculcates a local statistical properties of the protein surface at the atomic-group level to the 
prediction method (Kufareva et al 2007).  
The results (list of residues) are given in a tabular form with each predicted residue prioritized 
according to the likelihood of the residue to be in a protein-protein interface. The higher the 
probability, the more likely the residue would be located in an interface region of the protein. 
Buried residues are indicated in the results with a probability value of 0.0 while those residues 
likely to be interface regions are above 30. For this analysis, only those residues with a score 
above 30 were selected. The web server is available at the address: 
http://abagyan.ucsd.edu/PIER/pier.cgi?act=abstract 
 
 
4.4 Computation of Protein-Protein Interface Residues 
4.4.1 The Prediction Hit ("+") 
All six web server predictors mentioned above were used to analyze interfacial residues that 
are present in human BTK domains- PH, SH2 and Kinase. Each amino acid residue for all 
domains that were analyzed by all 6 predictors, a prediction hit by each predictor for all 
predicted amino acid residue was indicated as "+".   
 
4.4.2 Probability (Percentage)  Score 
A simple arithmetic scoring system was used to assign a score to each prediction hit of a 
residue in terms of a probability percentage. Hence, the sum of probability percentage for all 6 
predictors is 100%, with each predictor having a probability score of 16.66% for any residue. 
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For example, if only two out of all 6 predictors predict a residue A to be an interfacial residue, 
then the probability score would be calculated as: 
Probability score of residue A is  16.66% * 2 = 33.32% 
In pursuit of simplicity and avoidance of ambiguity, the probability score for each residue were 
presented in the form of color codes since all possible scores are results of the total amount of 
predictors. 
Table 4.1 showing the color code of probability percentages for a residue predicted to be in the 
protein-protein interface.  
Color Code Amount of Predictors Probability percentages % 
(16.66 * amount of predictors) 
 1 16.66 
 2 33.32 
 3 49.98 
 4 66.64 
 5 83.30 
 6 99.96 
 
4.4.3 Selection of Interfacial Residues 
Considering a total of six prediction results from different protein-protein interface predictors, 
the consequent volume of data generated from the analysis aroused the need to filter only 
those residues that are most likely to be found in the protein-protein interface. Therefore, 
where two or more predictors highlight a residue to be in protein-protein interface, those 
predicted residues were highlighted. 
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4.5 Rendering of Protein Structure Images 
Like the graphical interactive results obtained by using the PredUS (a protein-protein interface 
predictor web server) (Zhang et al., 2011), similar efforts were made using the VMD (Visual 
Molecular Dynamics) software (Humphrey et al., 1996). Only those interfacial residues 
predicted by two or more protein-protein interface predictors were rendered. Such graphical 
rendering of the protein structures portrayed the predicted residues in relation to: respective 
secondary structures (α-helices or β-strands );  residue accessibility (surface or buried residues); 
region of the protein. 
Graphical representations of the predicted residues in various conformations were designed in 
order to understand the region in which these interfaces are situated. In addition, possible 
implications of such predicted interfaces were analyzed by superimposing the predicted 
residues and the analyzed pathogenic SNPs dataset (associated with human BTK).  
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5 RESULTS 
Domain-wise analysis of protein-protein interface residues in human BTK protein was carried 
out using six server-based predictors with the exception of the SH3 domain, as stated earlier in 
the previous section: materials and method. For simplicity and coherency, the results from the 
domain analysis were tabularized in each section. 
  
5.1 Analysis of PH Domain 
The pdb file (1BTK) for BTK PH domain contained 170 residues. Using the UNIPROT annotation 
data of BTK for interface prediction of the PH domain (residue 3-133), two (meta-PPISP and 
cons-PPISP) out of the six protein-protein interface predictors did not highlight any interfacial 
residue in the PH domain between residues 3-133. However, predictions were made by these 
two web predictors (meta-PPISP and cons-PPISP) for residues between 134-170: 142, 164, 163, 
162, 161, 141, 140, 157, 165, 166, 167, 155 and 151.  
Although the above predicted residue positions, between position 134-170, were in the pdb file 
(1BTK) of PH domain, they have been annotated by UNIPROT (The UNIPROT Consortium, 2012 
as an active region in the human BTK protein known as 'Zinc finger'. Thus, predictions in the 
region were excluded from the analysis.  
Also, another basis for this shared characteristic is because both web server predictors (Cons-
PPISP and Meta-PPISP) share the same algorithm and are both from similar authors (Zhou 
group, 2007). Prediction results made by Meta-PPISP and cons-PPISP were all outside the 
region of the PH domain residues (3-133) as annotated by UNIPROT (Berman et al., 2000) but 
still in the 1BTK pdb file (with a total number of 170 residues). 
A total of 131 amino acid residues (between positions 3-133) from the PH domain were 
analyzed out of which 39 residues were predicted to be involved with a protein-protein 
interface. However, just one out of any of the six predictors predicted 37 of these 39 amino acid 
residues to be an interfacial residue (green colored in Table 5.1). Also, 2 of these 39 residues 
had a probability percentage of being an interface residue of 33.32% i.e. as described in Table 
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4.1, 2 out of any of the six predictors predicted them to be an interfacial residue (colored as 
light blue in Table 5.1). A graphical representation of all predicted residues can be seen in 
Figure 5.4. Correlating the predicted interface residues (39) and the known pathogenic SNPs in 
the PH domain protein, only one out of the recorded 28 polymorphic amino acid positions were 
predicted to be in the protein-protein interface: V64 had a pathogenic polymorphism amount 
of 4. 
Table 5.1 The table shows a cross analysis of disease-causing SNPs and secondary structure in 
PH domain of BTK using selected protein-protein interface predictors. The "+" denotes 
Prediction hit of those residues that were predicted to be in the interface region by any one of 
the predictors. 
SECONDARY 
STRUCTURE 
UNIPROT 
(WILD) 
POSITION 3-
133 
RESIDUE PATHOGENIC 
SNPs STATISTICS 
INTERFACE PREDICTORS 
Cons-
PPISP 
PredUS SPPIDER Meta-PPISP (cons-
PPISP, PINUP, 
Promate) 
PPI-Pred PIER 
 3 A    +    
4 V    +    
5 I    +    
Β-strand 6 L        
7 E    +    
8 S       + 
9 I       + 
10 F 1       
11 L 4       
12 K 1       
13 R        
 14 S 3       
15 Q        
16 Q        
17 K 1       
Β-strand 18 K        
19 K 2       
20 T        
 21 S        
22 P        
23 L        
24 N        
Β-strand 25 F 1       
26 K        
27 K 1       
28 R 40       
29 L        
30 F        
31 L 1       
32 L 5       
 33 T 6       
34 V        
35 H        
36 K        
37 L 1       
38 S 1       
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39 Y 7       
40 Y 5       
41 E        
42 Y   +     
43 D   +     
Turn  44 F   +     
45 E   +     
46 R   +     
47 G   +     
Β-strand 48 R   +     
49 R        
50 G        
51 S        
52 K   +     
53 K        
54 G        
55 S   +     
56 I 1       
57 D        
Helix  58 V        
 59 E      +  
60 K      +  
Β-strand 61 I 6       
62 T      +  
63 C      + + 
64 V 4     +  
65 E      +  
66 T      +  
 67 V        
68 V        
69 P        
70 E        
71 K        
72 N    +    
73 P        
74 P        
Helix  75 P        
76 E        
77 R        
 78 Q        
79 I        
80 P        
81 R        
82 R        
83 G        
84 E        
85 E        
86 S        
87 S        
88 E        
89 M   +     
90 E   +     
91 Q   + +    
92 I   +     
Helix 93 S        
94 I   +     
95 I   +     
96 E   +     
 97 R        
98 F 2       
99 P        
Β-strand 100 Y        
101 P        
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102 F        
103 Q 1       
104 V        
105 V      +  
106 Y      +  
 107 D      +  
108 E   +     
109 G        
110 P      +  
Β-strand 111 L 1       
112 Y 1       
113 V 1       
114 F        
115 S 1       
116 P        
 117 T 12       
118 E        
Helix 119 E        
120 L        
121 R        
122 K        
123 R        
124 W 3       
125 I      +  
126 H        
127 Q 1       
128 L        
129 K      +  
130 N    +    
131 V        
132 I      +  
 133 R      +  
 
Hyvönen et al. (1995) and Ferguson et al. (1995) described the structure of the PH domain of 
BTK to consist of two perpendicular anti-parallel β-sheets that make up the β-barrel, followed 
by a C-terminal amphipathic helix. In addition to the interface and pathogenic SNP analysis, 
further correlation between the secondary structures in the PH domain and the predicted 
interface residues as well as pathogenic SNPs residues was done. 
Table 5.2 Table showing the distribution of pathogenic SNPs and predicted interfacial in 
correlation to their secondary structures in the PH domain of Human BTK protein 
Color 
code 
 
Secondary 
structures 
Amount  of SNPs positions in 
secondary structures  
(Total = 28) 
Amount of residues predicted 
to be in interface region 
(Total = 39 ) 
 
Α-helices 2 (7.14%) 7 (17.95%) 
 
Β-strands 18 (64.29%) 13 (33.33%) 
 
Turns/loops 0 (0.00%) 4 (7.55%) 
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 As seen in Table 5.2, 33.33%  (13 residues) of the predicted interface residues are situated in β-
strands while approximately 18% were found to be embedded in the helical secondary 
structure of the PH domain protein.  
Using the VMD standalone computer software program (Humphrey et al., 1996), graphical 
illustrations of the location of the predicted interfacial residues were performed. Amongst the 
illustrations is a representation showing probable binding patches and pockets situated at the 
surface of the protein (Fig. 5.1a) and also in buried interfacial residues that is observable in the 
secondary structure representation (Fig. 5.1b).  
(a) (b)  
 Figure 5.1 (a) Surface representation of the PH domain showing the location of those 
interface residues predicted by at least two predictors (in red= C63 and Q91) coded as color 
'blue' in Table 5.1. (b) Also, cartoon structure of the PH domain showing the location of the 
predicted interface residues (C63 and Q91) by at least two predictors; the figure further depicts 
the location of the interface residues in the secondary structure of the PH domain.  
Additionally, upon mapping the pathogenic SNPs data set of the PH domain protein to their 
corresponding secondary structure, it was observed that 18 out of 28 SNPs positions (~ 65%) 
occur in regions of β-sheets, some of which are buried residues within the structure of the 
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protein. Just two out of the 28 pathogenic SNPs residue positions were found to be situated in 
α-helices. No known SNPs residue positions were observed in turns/loops. 
(a) (b)  
Figure 5.2 (a) Secondary structure representation showing the location of pathogenic SNPs 
residues (as red beads) in the PH domain. More of the SNPs residues (red balls) are located in 
the barrel structure of the beta-sheets than in α-helices. (b) Cartoon structure of the PH domain 
depicting those pathogenic SNPs residues highlighted according to their secondary structure: 
two residues occur in the helical structure (W124 and Q127); 18 residues are situated in the 
beta-strands (F10, L11, K12, K19, F25, K27, R28, L31, L32, T33, I56, I61, V64, Q103, L111, Y112, 
V113, S115). Most of the pathogenic SNPs are buried within the structure of the protein. 
(c) (d)  
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Figure 5.2 (c) and (d) shows two angles of transparent secondary structures of PH domain 
highlighting the pathogenic SNPs residue (W124 and Q127) located in the helical structure. 
Representations in Figure 5.2 correlates with earlier studies by Neuvirth et al. (2004) that 
suggested β-strands to be more favored at protein-protein interfaces, and therefore residue 
variations at such regions will most likely lead to disease conditions as observed in XLA and 
other BTK-related dysfunctions. Also, the likelihood of pathogenic variations in β-sheets 
increases the risk of the resultant (domain) protein to be dysfunctional or unable to fold 
properly. 
From the analysis of PPI prediction of the PH domain using the six predictors (PredUS, cons-
PPISP, PPI-Pred, meta-PPSIP, SPPIDER and PIER), mapping of the predicted PPI residues to the 
structure of the protein was carried out based on the amount of predictors that predicted a 
particular residue to be in an interfacial region. A visualization of possible binding patches on 
the surface of the BTK PH domain protein is seen in figure 5.3. 
(a) (b)  
Figure 5.3 Surf representation showing possible binding patches mapped to the surface of 
the PH domain based on the predicted interface residues derived from the above analysis. The 
amount of prediction hit for each residue was ascertained and represented in the a color code 
as shown in Table 5.1  (a) Two of the predictors highlighted just two residues to be an interface 
residue: C63 and Q91. (b) Here, predicted interface residues are depicted as binding patches on 
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the PH domain; only one out of any the six predictors predicted 39 residues to be in the 
interfacial region of the protein: A3, V4, I5, E7, S8, I9, Y42, D43, F44, E45, R46, G47, R48, K52, 
S55, E59, K60, T62, C63, V64, E65, T66, N72, M89, E90, Q91, I92, I94, I95, E96, V105, Y106, 
D107, E108, P110, I125, K129, N130, I132 and R133.  
The amount of predictors highlighting a residue to be in the interfacial region, is directly 
proportional to the probability of that residue being in the interface region. Therefore, for PH 
domain of human BTK, residues C63 and Q91 (predicted by two of the six predictors as 
represented in Figure 5.4a) has the highest probability of being interface residues. 
 
 
5.2 ANALYSIS OF  SH3 DOMAIN 
From the currently (August, 2012) available data set on XLA obtained from BTKbase 
(http://bioinf.uta.fi/BTKbase/) there were no entries for pathogenic SNPs existing in the SH3 
domain of human BTK. Hopefully in the nearest future, on-going research efforts in pathogenic 
SNP occurring in human BTK would provide substantial scientific evidence pointing to the SH3 
domain. 
 
5.3 ANALYSIS OF SH2 DOMAIN 
Examination of the pdb file 2GE9 for human BTK SH2 domain, which was obtained from the 
RCSB PDB (Berman et al.2000), showed stronger correlation between SNP residues and 
predicted interface residues. In accordance to the structure of SH2 domain (Huang et al, 2006) 
shown in Figure 2.5b, most of the predicted interfacial residues were situated in the β-strands 
due its abundance. Table 5.4 shows the statistical distribution of the predicted interfacial 
residues in respect to the secondary structures of the protein. 
Out of a total of the 97 residues in the pdb file of SH2 domain, 64 of them were predicted to be 
an interfacial residue by at least one or more of the six interface predictors used for the 
analysis. Residues W281, K284 and R288 all had a 67% probability percentage (i.e. they were 
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predicted to be interface residues by four out of the six interface predictors) of being an 
interfacial residue, among which R288 has a known pathogenic SNP count of 40.  
 
Table 5.3 The table shows a cross analysis of the prevalence of disease-causing SNPs in 
interface residues of human BTK SH2 domain. The "+" denotes those amino acid residues that 
were predicted to be in any interface region of the SH2 domain. 
PDB SEQ 
POSITION 
UNIPROT 
(WILD) 
POSITION 
RESIDUE SECONDARY 
STRUCTURE 
PATHOGENIC 
SNP 
STATISTICS 
INTERFACE PREDICTORS 
consPPISP PredUS SPPIDER Meta-PPISP (cons-PPISP, 
PINUP, Promate) 
PPI-Pred  PIER 
12 281 W Β-strand  +   + + + 
13 282 Y     + + + 
14 283 S   +   + +  
15 284 K  +  + + +  
16 285 H  +   +   
17 286 M  +   +   
18 287 T  +      
19 288 R Helix 40 + +  + +  
20 289 S   +     
21 290 Q        
22 291 A        
23 292 E   +   +  
24 293 Q        
25 294 L 1 +    +  
26 295 L 3     +  
27 296 K   +   +  
28 297 Q        
29 298 E        
30 299 G         
31 300 K      +  
32 301 E        
33 302 G 14 +    +  
34 303 G Β-strand  +   + +  
35 304 F  +   + +  
36 305 I  +    +  
37 306 V      +  
38 307 R 6 +  + +   
39 308 D 1    +   
40 309 S      +   
41 310 S Β-strand        
42 311 K   +     
43 312 A        
44 313 G         
45 314 K        
46 315 Y Β-strand  +   +   
47 316 T 1 +   + +  
48 317 V 1 +   + +  
49 318 S 3 +   + +  
50 319 V 1 +    + + 
51 320 F  +    +  
52 321 A      +  
53 322 K        
54 323 S        
55 324 T        
56 325 G        
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57 326 D   +     
58 327 P         
59 328 Q        
60 329 G        
61 330 V Β-strand        
62 331 I   +     
63 332 R 1       
64 333 H 1      + 
65 334 Y 2   +   + 
66 335 V    +   + 
67 336 V         
68 337 C Β-strand 1       
69 338 S        
70 339 T        
71 340 P Turn        
72 341 Q        
73 342 S        
74 343 Q Β-strand        
75 344 Y    +    
76 345 Y   +     
77 346 L 2  + +   + 
78 347 A  1  + +   + 
79 348 E   + +    
80 349 K   + +    
81 350 H Β-strand   + +    
82 351 L   + +    
83 352 F    +    
84 353 S        
85 354 T        
86 355 I Helix 3       
87 356 P       + 
88 357 E   +     
89 358 L 3   +    
90 359 I    +   + 
91 360 N    +   + 
92 361 Y 4   +   + 
93 362 H 2  + +   + 
94 363 Q   + +   + 
95 364 H  5   +    
96 365 N 1  + +    
97 366 S 1  + +    
98 367 A 2  + +    
99 368 G   + +    
100 369 L 2   +    
101 370 I 1   +   + 
102 371 S 3   +   + 
103 372 R 3  + +   + 
104 373 L Β-strand    +   + 
105 374 K 3   +   + 
106 375 Y        
107 376 P       + 
108 377 V         
 
In comparison to the PH domain, structural differences in the amount of β-strands in SH2 
domain appear to be higher than those in PH domain. Thus, this increases the likelihood of 
more interfacial residues being predicted in β-strands than α-helices for SH2 domain. The 
results from the analysis of the SH2 domain of the human BTK depicts strong statistical 
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correlations between interfacial residues and occurrence of pathogenic SNP. In addition to β-
strands being favored at interfacial regions (Neuvirth et al., 2004), the amount of pathogenic 
SNPs found in β-strands- 41%, suggests that they constitute a functional site or "hot spots". 
These hot spots are known to be evolutionarily conserved and highly susceptible to variation 
(Chen and Zhou, 2005). 
 
Table 5.4 showing the distribution of pathogenic SNPs and predicted interfacial residues in 
secondary structures in the SH2 domain of human BTK protein 
Color 
Code  
Secondary 
structure 
Amount  of SNPs positions 
(Total = 29) 
Amount of residues predicted 
to be in interface region 
(Total = 64 ) 
 
Α-helices 7 (24.14%) 14 (%) 
 
Β-strands 12 (41.38%) 30 (%) 
 
Turns/loops 0 (0.00%) 0   (0.00%) 
 
(a) (b)  
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(c)   (d)  
Figure 5.4 Structures of human BTK SH2 domain showing various binding patches formed 
by the sixty-four predicted interface residues based on the amount of web predictors. (a) 
Interfacial residues predicted by only one out of the six predictors: T287, S289, L295, K300, 
V306, D308, S309, K311, A321, D326, I331, H333, Y344, Y345, F352, P356, E357, L358, H365, 
L369 and P376. Of all these, six of them (L295, D308, H333, L358, H364 and L369) are known to 
contain pathogenic SNP that lead to XLA. (b) The highest amount of interface residues (26) that 
were predicted by only 2 out of the six predictors: H285, M286, E292, L294, K296, G302, I305, 
Y315, F320, Y334, V335, E348, K349, H350, L351, I359, N360, Y361, N365, S366, A367, G368, 
I370, S371, L373 and K374. Out of all these, L294, G302, Y334, Y361, N365, S366, A367, I370, 
S371 and K374 were known to undergo pathogenic SNP that result into XLA. 
 (c) Interfacial regions formed by the residues predicted by any 3 out of the six interface 
predictors: Y282, S283, G303, F304, R307, T316, V317, S318, V319, L346, A347, H362, Q363 and 
R372. The interfacial region is compact and isolated to one part of the protein. More than half 
of the predicted interface residues are known to undergo pathogenic SNP that leads to XLA. 
They include: R307, T316, V317, S318, V319, L346, A347, H362 and R372. (d) Shows the 
location of residues W281, K284 and R288. Among the trio, R288 is the only residue known to 
undergo pathogenic SNP that leads to XLA; it has the highest solvent accessibility area as seen 
in Figure 6.2 in the discussion.  
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(a) (b)  
Figure 5.5 (a) Interfacial heat map showing the predicted interface regions/binding patches 
according to the probability percentages. The darker the shade, the higher the amount of 
protein interface predictors that highlighted the predicted residues. (b) Surface representation 
of all pathogenic SNPs predicted to occur in all interfacial residues of the SH2 domain. Overall, 
the human BTK SH2 domain appear to have multiple interacting regions mostly on the surface 
but also within the molecule, given the ratio of predicted interface residues to total number of  
residues in the protein.  
 
 
5.4 ANALYSIS OF TK DOMAIN 
For the analysis of the tyrosine kinase (TK) or kinase domain of BTK, the pdb file '3P08' with a 
resolution of 1.5Å was used an the input in all six protein interface predictors. The BTK kinase 
domain made of two chains with a residue length of about 254 aa. Thirty-two percent (83) of 
these 254aa residues were predicted to be in the interface region of the protein by any one out 
of the six protein interface predictors.  
The highest probable (67%) interfacial residues, as seen in Table 5.5, were predicted by 4 out of 
the six predictors include: G409, T410, Q412, G414, V415 and Y617. 8 out of the 83 interface 
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residues by predicted by  3 of the six predictors; another 19 of the 83aa interfacial residues 
were predicted by 2 of the six predictors while over 60% (50) of the 83 residues were predicted 
by just one out of the six interface predictors.  
Cross analysis between the predicted interface residues and the residue positions of pathogenic 
variations in BTK kinase domain revealed that about 19% (16) of the predicted 83 interfacial 
residues undergo pathogenic SNP that is known to cause XLA. In comparison to PH and SH2 
domains, about 1.6% and 38.8% of the predicted interfacial residues are known to undergo 
pathogenic variations that leads to XLA.  
An amino acid of particular interest is arginine, which was one of the highest amino acids found 
in the BTK kinase interfacial regions (Table 6.1) as well as the amino acid residue having the 
highest amount of pathogenic variation in all domains analyzed. Detailed statistics about 
arginine and other amino acids have been highlighted in Table 6.1 of the discussion section.  
Table 5.5  A cross analysis of disease-causing SNPs in TK domain of BTK using selected protein 
interface predictors. The  " +" denotes those residues that were predicted to be in the interface 
region. 
PDB 
RESIDUE 
POSITION 
UNIPROT 
(WILD) 
POSITION 
RESIDUE SECONDARY 
STRUCTURE 
PATHOGENIC 
SNPS 
STATISTICS/POS 
INTERFACE PREDICTORS  
Consppisp Predus 
 
Sppider 
 
Meta-ppisp 
(cons-ppisp, 
pinup, promate) 
PPI-Pred 
n/a 
PIER 
 
10 402 L Β-strand 2       
11 403 T        
12 404 F   + +    
13 405 L  +  +    
14 406 K  +  +    
15 407 E  +  +    
16 408 L 3 +  +   + 
17 409 G  +  + +  + 
18 410 T   +  + +  + 
19 411 G Turn    + +  + 
20 412 Q  + + + +  + 
21 413 F 1 +  +   + 
22 414 G Β-strand 1 +  + +  + 
23 415 V  +  + +  + 
24 416 V  +  +   + 
25 417 K  +  +    
26 418 Y 1   +   + 
27 419 G 2       
28 420 K   +     
29 421 W   +     
30 422 R Turn   +     
31 423 G        
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32 424 Q        
33 425 Y Β-strand        
34 426 D        
35 427 V        
36 428 A    +   + 
37 429 I 1 +  +    
38 430 K 6 +  +    
39 431 M  +  +    
40 432 I  +  +    
41 433 K   +  +    
42 434 E        
43 435 G    +    
44 436 S    +    
45 437 M        
46 438 S        
47 439 E Helix        
48 440 D        
49 441 E        
50 442 F        
51 443 I        
52 444 E        
53 445 E 1       
54 446 A        
55 447 K        
56 448 V        
57 449 M        
58 450 M 1       
59 451 N    +     
60 452 L 2       
61 453 S   +     
62 454 H 2       
63 455 E   +     
64 456 K   +     
65 457 L        
66 458 V   +     
67 459 Q        
68 460 L Β-strand   +    + 
69 461 Y        
70 462 G 4       
71 463 V        
72 464 C        
73 465 T         
74 466 K        
75 467 Q Β-strand        
76 468 R        
77 469 P        
78 470 I  +      
79 471 F        
80 472 I        
81 473 I        
82 474 T        
83 475 E         
84 476 Y 3       
85 477 M 1      + 
86 478 A        
87 479 N     +   
88 480 G       + 
89 481 C     +  + 
90 482 L Helix         
91 483 L   +  +  + 
92 484 N   +  +  + 
93 485 Y     +   
94 486 L 2       
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95 487 R     +  + 
96 488 E      +   
97 489 M Helix     +   
98 490 R     +   
99 491 H        
100 492 R         
101 493 F        
102 494 Q        
103 495 T Helix        
104 496 Q        
105 497 Q        
106 498 L        
107 499 L        
108 500 E   +     
109 501 M 1       
110 502 C 5       
111 503 K        
112 504 D 4       
113 505 V 1       
114 506 C 11       
115 507 E   +     
116 508 A 1       
117 509 M 12       
118 510 E   +     
119 511 Y 1       
120 512 L 5       
121 513 E        
122 514 S         
123 515 K   +     
124 516 Q        
125 517 F        
126 518 L 1       
127 519 H 2       
128 520 R 19   +    
129 521 D 4   +    
130 522 L 1       
131 523 A 2       
132 524 A Helix  1       
133 525 R 18   + +   
134 526 N 1       
135 527 C Β-strand 3       
136 528 L       + 
137 529 V        
138 530 N         
139 531 D        
140 532 Q   +     
141 533 G        
142 534 V        
143 535 V Β-strand 3       
144 536 K        
145 537 V 1       
146 538 S  1       
147 539 D    +    
148 540 F 2       
149 541 G 2       
150 542 L Helix 3       
151 543 S     +   
152 544 R 11   +    
153 545 Y        
154 546 V  1       
155 547 L        
156 548 D        
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157 549 D Helix 1       
158 550 E        
159 551 Y 1       
160 552 T        
161 553 S         
162 554 S        
163 555 V Turn         
164 556 G        
165 557 S         
166 558 K        
167 559 F 1   +    
168 560 P     +   
169 561 V Helix         
170 562 R 28    +   
171 563 W 1       
172 564 S         
173 565 P 2       
174 566 P Helix  1      + 
175 567 E 3       
176 568 V        
177 569 L 2      + 
178 570 M       + 
179 571 Y    +    
180 572 S        + 
181 573 K        
182 574 F        
183 575 S 4       
184 576 S Helix         
185 577 K 2       
186 578 S 2       
187 579 D 3       
188 580 I        
189 581 W 5       
190 582 A 8       
191 583 F 2       
192 584 G 7       
193 585 V 1       
194 586 L        
195 587 M 2       
196 588 W 2       
197 589 E 6       
198 590 I 1       
199 591 Y 2       
200 592 S Turn  2       
201 593 L     +   
202 594 G 18       
203 595 K    +  +   
204 596 M        
205 597 P Turn  2       
206 598 Y 4  +     
207 599 E   + + +   
208 600 R   + + +   
209 601 F      +   
210 602 T        
211 603 N Helix     +    
212 604 S    +    
213 605 E        
214 606 T 2       
215 607 A 5   +    
216 608 E        
217 609 H   +     
218 610 I        
219 611 A        
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220 612 Q  1       
221 613 G 7       
222 614 L   +     
223 615 R 3       
224 616 L 6       
225 617 Y   + + +  + 
226 618 R    + +   
227 619 P 6       
228 620 H    + +   
229 621 L     +   
230 622 A 3       
231 623 S 3       
232 624 E Helix         
233 625 K        
234 626 V 1       
235 627 Y    +    
236 628 T    +    
237 629 I        
238 630 M 6       
239 631 Y        
240 632 S        
241 633 C  1       
242 634 W 3       
243 635 H        
244 636 E        
245 637 K        
246 638 A Helix        
247 639 D        
248 640 E        
249 641 R  15       
250 642 P 1       
251 643 T 1       
252 644 F Helix 4       
253 645 K   +     
254 646 I        
255 647 L 4       
256 648 L 1       
257 649 S   +     
258 650 N        
259 651 I 2       
260 652 L 1       
261 653 D        
262 654 V        
263 655 M        
 
Table 5.6 Distribution of pathogenic SNPs and predicted interfacial residues in secondary 
structures of human BTK kinase domain 
Color Secondary 
Structure 
Amount  of AA 
positions with 
SNP (Total = 91) 
Amount of AA positions 
predicted as interfacial 
residues (Total = 83) 
 Α-helices 45 (49.45%) 19 (22.89%) 
 Β-strands 10 (10.99% ) 20 (24.10%)  
 Turns 5 (5.49%) 8 (9.64%) 
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From the analysis of kinase domain, more of the pathogenic SNPs were observed to occur in α-
helices than β-strands; according to the results of the prediction in Table 5.5, β-strands were 
observed to be more dominant in interfacial regions.  
(a)  (b)  
(c)  
Figure 5.6 Structural representations of BTK kinase domain showing the predicted 
interfacial residues with probability percentage higher than 30% i.e. residues predicted by two 
or more protein interface predictors. (a) Cartoon representation of interfacial facial residues 
(F404, L405, K406, E407, K417, Y418, A428, I429, K430, M431, I432, K433, L460, C481, R487, 
R525, K595, R618 and H620) having a probability percentage of 33%. (b) Structural positions of 
all eight interfacial residues (L408, G411, F413, V416, L483, N484, E599 and R600) predicted by 
any 3 of the six interface predictors. Here, more interfacial residues (L408, G411, F413, V416, 
L483 and N484) are situated in chain A of the BTK kinase domain (c) Structural orientation of 
interface residues having a probability percentage of 67%. They include: G409, T410, Q412, 
G414, V415, Y617. Out of these, five of the interfacial residues (G409, T410, Q412, G414 and 
V415) are located in chain B of the kinase domain. 
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6 DISCUSSION AND CONCLUSION 
6.1. Structural analysis and implication 
6.1.1 PH Domain 
In the analysis of PH domain, only one (V64) out of the 28 pathogenic SNPs residues was 
predicted to be situated in an interface region (see Figure 6.1). However, for the predicted 
interface residue, the amount of SNPs occurring in the β-strand structure is higher than those 
occurring in α-helices: 64.29% and 7.14% respectively (see Table 5.3). Therefore, since it has 
been suggested in earlier studies by Neuvirth et al. (2004) that interface regions have a 
preference for β-strands. This statistics regarding β-strands is in accordance to such studies.  
(a) (b)  
Figure 6.1 (a) Cartoon structure of BTK PH domain showing the location of the small 
hydrophobic valine residue located at position 67 (atom represented in red); it was discovered 
to be both a pathogenic SNPs residue and also an interface residue (V64). (b) Additionally, 
surface representation of the residue V64 (red patch) suggests that it has a relatively low 
accessibility. 
Only the PIER protein interface predictor tool highlighted V64 as a likely interface residue. 
Kufareva et al. (2007) developed the protein-protein interface prediction tool- PIER based on 
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local statistical properties of a protein surface derived at the level of atomic groups. This 
prediction web server functions by combining (i) statistically derived interatomic contact 
potentials, (ii) physical descriptors, such as observed solvent accessibility for separate atomic 
groups within amino acids, and (iii) sequence alignment based features, in particular, three 
different conservation scores (frequency-based, similarity matrix-based, and entropy-based) 
(Kufareva et al., 2007).  
The combination of the above methods was another reason PIER was chosen for this analysis. 
Porollo and Meller (2012) observed that the overall performance of PIER prediction tool is 
relatively dependent on the quality of pdb structure. Given 1BTK has a resolution of 1.60 Å from 
the PDB, we safely infer that the credibility of V64 being an interface residue is reliable.  
The preference for secondary structures, such as β-strands, in interface regions may be due to 
the fact that β-strands are more flexible structures and are often able to form close contact 
across interfaces than α-helices (Neuvirth et al., 2004). Variations occurring in such interfacial 
regions (known to be populated with β-strands) playing significant roles in biological processes 
is likely to account for certain observed phenotypic disease conditions as seen in the XLA. 
As stated earlier were just one out of the 28 known pathogenic SNPs was predicted to be in 
interfacial region, this finding could suggest that most of the known pathogenic SNPs residues 
are embedded within the structure of the protein. For some of the predictors with a residue 
accessibility based algorithm, these predictors are unable to effectively analyze such residues 
and thereby producing false negative results. Figure 5.2 shows the location of the pathogenic 
SNPs amongst which most are buried.  
Shen and Vihinen (2004) suggested that the physiochemical properties of the amino acid 
residues found in the PH domain contain a substantial amount of hydrophobic residues. This 
implies that the high hydrophobicity of the residues buried in the protein are relatively involved 
in the folding of the functional quaternary BTK protein, thus, leading to the burying of most 
interfacial residues when the protein is unbound. 
 
64 
 
6.1.2 SH2 and TK Domain 
Earlier studies have shown the conservation of two functionally important  residues: R288 and 
R307, in the human BTK SH2 domain (Tzeng et al. 2000). From our analysis, Figure 5.5d shows 
the representation of those interface residues predicted by four out of the six predictors used.  
The residues W281, K284 and R288 form a cluster at the proximal end of the SH2 domain, thus, 
it suggests the likelihood of an interfacial region. Although no known SNP occur in W281 and 
K284, however high amount of SNP occurring at R288 further supports the likelihood of an 
interfacial region present at the proximal end of the human BTK SH2 domain.  
     
Figure 6.2 Surface representation of SH2 domain showing the accessibility of R288 (in red) 
to the surface of the protein. Although four out of the 6 interface predictors highlighted W281 
and K284 as interface residues, they are however barely accessible to the surface of the 
protein. It is possible that residues W281 and K284 have intra-domain binding activity within 
the SH2 domain; they could as well be crucial residues of buried interfacial regions that are only 
functional when the conformation of the SH2 domain changes in accordance to specific binding 
partners.  
In addition, Pekka et al., (2000) highlighted six key residues that facilitates the phosphotyrosine-
binding property of BTK SH2 domain in which pathogenic variations lead to XLA. These residues 
include: G302, R307, L358, Y361, H362 and I370. Similarly, results from interfacial residue 
prediction also correlated with all the above listed residues as seen in Table 5.3.  
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(a) (b)   
Figure 6.3 (a) Structural representation of predicted interfacial residues G302, R307, L358, 
Y361, H362 and I370 in BTK SH2 domain that are known to possess ligand-biding specificity to 
phosphotyrosine containing residues such as BLNK (Hashimoto et al. 1999). Given that 
pathogenic variations in functionally important residues ultimately lead to disease phenotypes 
(Pekka et al.,2000), inferably, the above listed residues are key components of interfacial 
regions/binding pockets in the SH2 domain. (b) Predicted (BTK SH2 domain) interfacial arginine 
residues R288 and R307 whose peptide-binding affinity in the phosphotyrosine binding pocket 
decreases by 200-fold in cases of XLA (Pekka et al., 2000). As at the time of this analysis, R288 
and R307 have a total pathogenic variation count of 40 and 6 respectively.  
 
6.2. Effect on binding activity 
Primarily, PH domains are involved in protein–protein interactions or similar protein-lipid 
interactions and consequently these interactions or cellular localizations control the regulation 
of specific enzyme functions, as described by Musacchio et al. (1993); Lemmon et al. (1996) and 
Li et al. (1997). Amongst these interacting molecules, phospatidylinositol 3,4,5-trisphosphate 
(PIP3)  is a known molecule whose interaction with the PH domain affects the overall activity of 
the BTK protein (Fakuda et al., 1996).  
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Through computer modeling, observed residues that are essential for the binding of PIP3 to the 
PH domain are: K12, F25, R28 respectively (Ferguson et al., 1995; Fakuda et al., 1996; Salim et 
al., 1996; Rameh et al. 1997). In addition, annotated binding sites from the Uniprot entry (Id- 
Q06187) also included R28. Other binding sites from Uniprot sequence annotation are: K26,  
Y39 and K53.  
From our analysis, Figure 6.1 shows the location of the only predicted interface residue- V64, 
that is also known to have pathogenic SNPs (V64D and V64F). Structural analysis by Hyvönen 
and Saraste (1997) showed that single nucleotide polymorphisms in residue V64 affect the 
stability and/or folding the PH domain because V64 is part of the hydrophobic core and is fully 
conserved in all proteins containing both the PH domain and BTK motif.  
Analytic cross-referencing of the prediction results with existing literature earlier discussed 
revealed the insufficient ability of all six predictors to correctly predict the binding sites in the 
PH domain, except for the residue Lys12. Other residues F25, K26, R28, Y39 and K53 were not 
identified to be in a protein-protein interface region.  On the other hand, the residues K12, F25, 
R28 and Y39 are implicated as pathogenic SNPs in the BTK protein (Li et al., 1995; Vihinen et al., 
1995). 
 (a)     (b)     
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(c)    
Figure 6.4 (a) Location of all residues (K12,F25,K26,R28,Y39 & K53) associated with PIP3 
binding as suggested by previous literature (Ferguson et al., 1995; Fakuda et al., 1996; Salim et 
al., 1996; Rameh et al. 1997). All residues are located in the β-barrel structure of the PH 
domain. (b) Surface representation of all six residues (from the previous literature) appear to 
form a "pocket"-like protein-protein interface with about half of the residues buried  (c) 
Lysine12 (K12) was the only residue predicted by one of the six predictors. 
 
Although the SNP residues had an uneven distribution, R28 was the only residue with a total of 
40 pathogenic SNPs. R28 was not predicted to be an interface residue by any of the six 
predictors used during the analysis even though the R28 residue is situated in a β-strand as 
shown in  the structure secondary structure organization of the PH domain from Table 6.1. 
More also, studies by Neuvirth et al. (2004) however suggests that a β-sheets are favored in 
interface regions. Thus, given a protein interface predictor with better accuracy of prediction, 
the extent of evolutionary conservation and mutagenic frequency of R28, it suggests that the 
residue-R28 constitutes a functional site in the PH domain of human BTK. 
 
LYS12 
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(a)        (b)  
Figure 6.5 (a) The highly polymorphic R28 residue (dotted pink) is located on a β-strand 
buried within the structure of the PH domain protein. This might account for the inability of any 
of the predictors to be predict R28 as a probable protein-protein interface (b) The R28 residue 
is shown alongside the resultant predicted interface residues (red) from this analysis.  
Also, in line with an earlier study by Vihinen et al. (1998), single nucleotide variations in R28 is 
associated to XLA in humans; given that β-sheets are more likely to be involved in interfacial 
regions. Likewise, one can infer that pathogenic variations in the β-strand structure where 
residue R28 is situated supports previous findings that associates single nucleotide variations in 
R28 as a genetic cause of XLA in humans (Vihinen et al., 1998) and in experiments carried out in 
mice (Thomas et al.,1993; Rawlings et al.,1993). 
 
6.3 Amino acid distribution across interfacial regions of BTK PH, SH2 and 
Kinase domains 
Statistical analysis of all predicted interface residues, irrespective of the number of interface 
predictors, was carried out to investigate the presence of any correlation with those residues 
with pathogenic variations (SNP). Also, this was done to determine the possibility that certain 
amino acids are more favored than others in the interface regions of human BTK.  
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Table 6.1 Domain-wise distribution of interfacial and SNP residues in BTK domains: PH, 
SH2 and TK 
Amino Acid 
Residue 
PH (170aa) 
Interface (SNP) 
SH2 (97aa) 
Interface (SNP) 
Tyrosine Kinase Domain (267aa) 
Interface (SNP) 
 
Total 
Interface (SNP) 
Approximate 
Ratio 
Interface : SNP 
A 1 (0) 3 (3) 2 (20) 6 (23) 1 : 4 
*R 3 (42) 3 (53) 9 (110 ) 15 (205) 1 : 14 
N 2 (0) 2 (1) 4 (1) 8 (2) 1 : 0.3 
D 2 (0) 2 (1) 2 (13) 6 (14) 1 : 2.3 
C 1 (0) 0 (1) 1 (20) 2 (21) 1 : 11 
Q 1 (2) 1 (0) 2 (1) 4 (3) 1 : 0.8 
E 7 (0) 3 (0) 7 (10) 17 (10) 1 : 0.6 
*G 1 (0) 3 (8) 5 (45) 9 (53) 1 : 6 
H 0 (0) 5 (8) 2 (4) 7 (12) 1 : 1.7 
I 7 (7) 4 (4) 3 (4) 14 (15) 1 : 1.1 
L 0 (16) 7 (12) 9 (33) 16 (61) 1 : 3.8 
K 3 (5) 6 (3) 9 (8) 18 (16) 1 : 0.9 
M 1 (2) 1 (0) 4 (21) 6 (23) 1 : 3.8 
F 1 (4) 3 (0) 4 (10) 8 (14) 1 : 1.8 
P 1 (0) 2 (0) 1 (13) 4 (13) 1 : 3.3 
*W 0 (3) 1 (0) 1 (12) 2 (15) 1 : 8 
Y 2 (13) 6 (6) 6 (12) 14 (31) 1 : 2.2 
V 3 (5) 4 (2) 3 (8) 10 (15) 1 : 1.5 
S 2 (5) 5 (7) 7 (14) 14 (26) 1 : 1.9 
T 2 (9) 3 (1) 2 (3) 7 (13) 1 : 1.9 
TOTAL 40 (113) 64 (110) 83 (362)   
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From the statistical analysis of all predicted interface residues across the human PH, SH2 and TK 
domains, the net amino acid distribution was calculated independent of the residue positions. 
Results from the interface-to-SNP amino acid ratio in Table 6.1 was considered domain-wise 
rather than generalizing the amino acid distribution across the entire molecule given that only 
PH, SH2 and TK domains were analyzed- they are not the only interfacial regions on the BTK 
molecule. 
The BTK domains individually possess peculiar properties that capacitate them to interact with 
various signaling molecule, thus, enabling the molecule as a whole to carry out various 
biological processes. Qin and Chock (2001) demonstrated that pathogenic variations in any of 
these BTK domains: PH (R28C), SH2(R307A) or TK(R525Q), would reduce or totally inhibit the 
function of the whole BTK molecule.  
Statistical analysis shows that lysine was the most abundant interfacial amino acid residue in all 
three domains (PH, SH2 and TK). Figure 2.2 shows the schematic property of lysine: positively 
charged, polar, ability to form salt-bridges, amphipathic etc. Of interfacial importance from all 
these properties is the amphipathicity of lysin i.e. it allows hydrophobic interactions in the side 
chain close to the backbone while the terminal side chain remains polar. This unique feature 
enables part of the side chain to be buried within the protein and the remaining part on the 
surface of the protein- making it an optimal interfacial residue.  
Glycine, tryptophan and arginine had an interface-to-SNP ratio of 1:6, 1:8 and 1:14 respectively. 
Even though arginine was the fourth most abundant residue across all interface regions of the 
three domains, however, it had the highest interface-to-SNP ratio. Cross referencing this result 
with the studies by Qin and Chock (2001) on implications of pathogenic variations on key 
arginine residues in BTK, results in Table 6.1 suggests that arginine residues appear to fairly 
abundant in interface regions and they also constitute functional sites of the BTK PH, SH2 and 
TK domains.  
Since evolutionary conserved residues: in BTK domains: PH (R28C), SH2(R307A) and TK(R525Q), 
are usually key residues of functional importance, therefore, the count of pathogenic variations 
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of arginine residues across all three domains as seen in Table 6.1 also strengthens the result 
that arginine is abundant at interfacial regions of the protein due to its function. 
(a) (b)  
(c)  
Figure 6.6 Structural representations of predicted interfacial arginine residues in BTK PH, 
SH2 and TK domains. (a) Surface representation of all three interfacial arginine residues R46, 
R48 and R133 in BTK PH domain. All residues are situated at the surface of the protein, residues 
R46 and R48 appears to be a constitute of binding site. (b) Interfacial arginine residues R288, 
R307 and R372 are shown in BTK SH2 domain. Here also, known phosphotyrosine interacting  
residues R288 and R307 appear as constituent residues of a bind site. (c) Dimeric structure of 
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BTK kinase domain showing the location of arginine residues. Most of the arginine residues are 
not easily accessible to the surface of the protein.  
Adequate efforts and resources should be channeled into research aimed at illuminating the 
intricacies behind interactions occurring at interface regions of proteins. In the nearest future, 
the emergence of better interface predictors will greatly improve the accuracy of protein-
protein interfacial region prediction. Furthermore, as more refined and precise methods of 
gene sequencing emerging, more evidence will emerge on the various types of pathogenic 
variations that occur in β-strand structure that are present in protein interfaces, both in 
homogenous or heterogeneous complexes- transient  or obligatory. 
Knowledge of interfacial regions on proteins including binding sites and docking regions are 
pivotal in the design of effective therapeutic agents in pharmaceutical industries as well as 
medicine. Adequate knowledge on specific interfacial residues that undergo disease-causing 
variations can elucidate which of the interfacial amino acid residues should be the target of an  
interface-focused gene therapy. 
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8 APPENDICES 
 
Figure 8.1 Heat map representation of human BTK PH domain showing interfacial regions. 
Image generated from PredUs protein interface predictor web server designed by Zhang et al. 
(2010); Zhang et al.(2011) and Fisher et al.(2011). 
 
Figure 8.2 Heat map showing interfacial regions of the human BTK SH2 domain. Image 
generated from PredUs protein interface predictor web server designed by Zhang et al. (2010); 
Zhang et al.(2011) and Fisher et al.(2011). 
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Figure 8.3 Heat map showing interfacial regions of the human BTK kinase domain. Image 
generated from PredUs protein interface predictor web server designed by Zhang et al. (2010); 
Zhang et al.(2011) and Fisher et al.(2011). 
 
